• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

adhd medication Uk elvanse Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data on how exposure to ADHD for a long time could affect a fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to weigh the benefits of taking it versus the risks for the foetus. Physicians don't have the information needed to provide clear recommendations however they can provide information regarding risks and benefits that aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a large sample-based case control study to examine the prevalence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to make sure that the classification was correct and to reduce any bias.

The study of the researchers was not without limitations. The most important issue was that they were not able to differentiate the effects of the medication from the effects of the disorder at hand. This makes it difficult for researchers to determine if the few associations observed between the exposed groups were due to the use of medications, or if they were caused by the presence of comorbidities. Additionally, the researchers did not examine long-term offspring outcomes.

The study did reveal that infants whose mothers had taken ADHD medication during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or taken off their medication prior to or during pregnancy. This was due to central nervous system disorders, and the increased risk for admission was not found to be affected by the type of stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy were also at an elevated chance of having a caesarean birth or having a baby with a low Apgar score (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the higher benefit for both mother and child of continuing treatment for the woman's disorder. Physicians should speak with their patients about this issue and, if possible, help them develop coping skills that could reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to continue treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are frequently taken without clear and authoritative evidence. Instead, physicians must take into account their own experience in conjunction with the experiences of other physicians and the research on the topic.

The issue of risk to infants is extremely difficult. The research that has been conducted on this topic is based on observation rather than controlled studies, and many of the findings are conflicting. Most studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects leading to abortions or terminations of pregnancy. The study presented in the journal club addresses these limitations, by examining both information on deceased and live births.

Conclusion: While some studies have found a positive correlation between adhd medication for women medications and certain birth defects, other studies have not found a correlation. Most studies show that there is a neutral, or somewhat negative, impact. In every case an in-depth study of the benefits and Adhd medication Uk elvanse risks should be conducted.

For many women with ADHD, the decision to discontinue medication is difficult if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication adults ADHD medications during pregnancy can increase depression and feelings of being isolated. A loss of best medication for adhd and anxiety may also affect the ability to drive safely and to perform work-related tasks which are crucial aspects of normal life for those with ADHD.

She suggests women who are uncertain about whether or not to stop medication in light of their pregnancy should consider educating family members, friends, and coworkers on the condition, its impact on daily functioning, and on the advantages of continuing the current treatment plan. It will also help a woman feel confident about her decision. Certain medications can pass through the placenta. If a patient decides to stop taking her ADHD medication while breastfeeding, it's important to be aware that the medication could be transferred to the baby.

Risk of Birth Defects

As the use and abuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD) is increasing the concern over the potential effects of these drugs on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Utilizing two huge data sets, researchers were able to analyze more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the overall risk is low, first-trimester adhd medication guanfacine exposure to medication was associated with slightly higher risk of certain heart defects, like ventriculoseptal defect.

The researchers of the study could not discover any link between early medication usage and other congenital anomalies, like facial deformities, or club feet. The results are consistent with previous studies that have shown the presence of a small, but significant increase in the risk of heart malformations among women who began taking ADHD medications prior to the time of the birth of their child. This risk increased during the latter part of pregnancy, as many women begin to discontinue their ADHD medications.

Women who took ADHD medication in the first trimester were more likely to need a caesarean and also have an insufficient Apgar after birth and had a baby that required help breathing at birth. The researchers of the study could not remove bias in selection since they limited their study to women without other medical conditions that might have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of doctors who encounter pregnant women. The researchers suggest that while discussing risks and benefits are important, the choice regarding whether or not to stop medication should be made in light of the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also advise that while discontinuing the medications is an option, it is not an option that is recommended due to the high prevalence of depression and other mental health problems for women who are expecting or recently postpartum. Additionally, research suggests that women who stop taking their medications will have a difficult adjustment to life without them after the baby is born.

Nursing

The responsibilities of a new mom can be overwhelming. Women who suffer from ADHD who have to manage their symptoms while attending physician appointments and making preparations for the arrival of a baby and adjusting to new household routines may face a lot of challenges. As such, many women decide to continue taking their ADHD medications throughout pregnancy.

The risk to a nursing infant is low because the majority of stimulant medications passes through breast milk at low levels. However, the rate of exposure to medications by the infant can differ based on dosage, frequency it is taken and the time of the day the medication is administered. In addition, individual medications enter the baby's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn is not yet fully understood.

Due to the absence of research, some physicians may be inclined to discontinue stimulant medication during the course of pregnancy. This is a difficult decision for the patient, who must weigh the benefits of keeping her medication against the potential risks to the embryo. As long as there is no more information, GPs should ask all pregnant patients about their experience with ADHD and whether they plan or are taking to take medication during the perinatal time.

A growing number of studies have shown that women can continue their ADHD medication while they are pregnant and nursing. This has led to many patients opt to do this, and in consultation with their doctor they have found that the benefits of keeping their current medication far outweigh any risks.

It is essential for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss the medication they are taking with their physician, and the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation is also needed to help pregnant women with intuitive adhd medication recognize the signs and the underlying disorder. They should also be informed about treatment options and reinforce coping mechanisms. This should be a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include discussion of a management plan for both the mother and child, monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.